AirXpanders Inc

The concept of AeroForm came to Dr. Dan Jacobs, a Silicon Valley-based plastic surgeon, while he was on a bike ride. He was thinking about his breast reconstruction patients, and the process of having to endure needle injections with saline expanders and began to wonder if there could be another way. That’s when he came upon the idea of using a tiny canister of compressed gas, similar to the one he carried to fix a flat tire, inside of a tissue expander to make the tissue expansion process easier and more comfortable for his breast reconstruction patients. With this seed of an idea and his Silicon Valley contacts, AeroForm was born.

AeroForm was granted U.S. FDA de novo marketing authorization in 2016, received CE mark in Europe in 2012 and Australian TGA certification in 2013.

Email Alerts for:
ASX:AXP

Latest Media Releases

AirXpanders, Appendix 4C - Quarterly Cash Flow Report and Business Update

Highlights for the quarter ended 30 September 2017 Revenue increased to US$1.2 million compared to US$0.2 million in Q3 2016; driven primarily by U.S. sales growth U.S. unit sales grew 108% co…

AirXpanders Announces 5th Prospective Trial Confirms Physician and Patient Satisfaction, Ease of Use and Convenience with AeroForm® Tissue Expander System

- Data on delivery of radiation with AeroForm in vivo with no increased toxicity also presented PALO ALTO, CA, United States, October 9, 2017 — AirXpanders, Inc. (ASX:AXP) (AirXpanders or Com…

AirXpanders Announces Completion of Manufacturing Transfer to Costa Rica

PALO ALTO, CA, United States, Sept. 28, 2017 — AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), a medical device company focused on the design, manufacture, sale and distribution of the Ae…